University of Oklahoma advances work on West Nile vaccine

There have been nearly 2,000 reported cases of West Nile virus across 48 states so far this year, making it the worst outbreak of its kind in U.S. history, according to the Centers for Disease Control and Prevention (CDC). In Oklahoma, one of the worst-hit states, researchers at the University of Oklahoma Health Sciences Center are working on a West Nile vaccine, and the findings have been promising so far, according to a report from KCEN-TV. More

Suggested Articles

Merck has a big target in mind for its pneumococcal vaccine V114: Prevnar 13, the world's best-selling shot—and its phase 3 program shows it.

A Lancet Infectious Diseases study shows antibody response persists for two years or more after a single shot of Merck’s rVSV-ZEBOV vaccine.

The partnership aims to make the production of vaccines that use adenovirus as vectors more cost-effective and contamination-free.